Print Issues

Volume 75, Issue 3


Valuing Medical Innovation

by  Daniel J. Hemel & Lisa Larrimore Ouellette

Scholars and policymakers across the ideological spectrum agree that the U.S. drug pricing system is deeply flawed. Most reform proposals focus on one symptom: high prices for existing drugs. But high prices aren’t all that ails the U.S. drug pricing system: Current law also provides weak incentives for medical innovation across wide areas, including vaccines,…


Reversing Reverse Mainstreaming

by  Yaron Covo

For almost five decades, school districts in the United States have been required by federal law to integrate disabled students into mainstream classrooms. Many educational agencies, however, have also done the opposite: They have included nondisabled students in special education settings. This practice, now known as “reverse mainstreaming,” has historical roots in nineteenth-century educational programs…


Self-Imposed Agency Deadlines

by  Mariah Mastrodimos

Federal agencies impose deadlines on themselves through their rulemaking powers, even though these regulatory deadlines carry costs for the agencies. When an agency misses its own regulatory deadline, citizens may sue the agency to force it to act. This presents two puzzles: Why do agencies self-impose internal deadlines? And why do courts enforce them? This…


The Caregiver Conundrum

by  Grace Rehaut

Today, a woman in the United States who becomes pregnant will gain access to special legal protections at her workplace, including a right to nondiscrimination and non-harassment by her employer. Yet, after giving birth and returning to work, she will watch those legal protections dissipate. Title VII of the Civil Rights Act, the federal law…